Amgen meets analyst estimates, but shares drop on Q2 earnings decline
Amgen’s revenues climbed 6 percent in the second quarter, to $6.2 billion, despite the COVID-19 pandemic limiting hospital and physician operations and putting a hitch in diagnosis and treatment for many patients. Amgen’s earnings, announced July 28, met average analyst estimates. However, a 17 percent overall decline in net income for the Thousand Oaks biotech Read More →
Read More →American Riviera Bank earnings tick up in Q2
American Riviera Bank saw a slight rise in its unaudited net income in the second quarter, but the Santa Barbara-based bank is still facing a decreased net income for the year as it prepares for loan losses. The bank’s unaudited net income in the second quarter of 2020 was $1.56 million, up from $1.51 million Read More →
Read More →
Pandemic still top concern for Community West following Q2 earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Region braces for end of UI benefit bonus
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Teledyne stock climbs as Q2 earnings beat analyst estimates
Second-quarter sales for Thousand Oaks-based Teledyne Technologies dipped 5 percent to $743.3 million, and net income beat analyst estimates, sending the stock up 2.5 percent in early trading. Net income fell around 10 percent compared to the previous year’s second quarter to $93.7 million, or $2.48 per share, squarely beating analyst predictions of around $2 Read More →
Read More →Sierra Bancorp Q2 earnings down
Sierra Bancorp, a Porterville-based banking company with 11 branches in the Tri-Counties, announced July 20 that its quarterly earnings were slightly down compared to the same period in 2019, led by a lower consolidated net income and lower return on both average assets and average equity. The parent company of Bank of the Sierra declared Read More →
Read More →Amgen puts $421M into BeiGene
Thousand Oaks biotech giant Amgen has upped its investment in Chinese oncology research firm BeiGene by $421 million. Amgen’s new investment, announced July 13, will allow the company maintain its ownership interest in BeiGene at 20.3 percent following a direct offering by the Chinese firm. Amgen shares rose more than 1 percent following the news Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
